CSIMarket


Purple Biotech Ltd   (PPBT)
Other Ticker:  
 

Purple Biotech Ltd

PPBT's Fundamental analysis








Purple Biotech Ltd 's sales fell in IV. Quarter 2022 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -2.27 %

Purple Biotech Ltd 's net income grew by 17.83 % in IV. Quarter 2022 year on year, above company average,

More on PPBT's Growth


Purple Biotech Ltd
achieved net income of 22 millions in the past twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.


More on PPBT's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Purple Biotech Ltd
achieved net income of 22 millions in the past twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.